Selected References

Virology

Head of Institute:
Prof. Dr. med. Klaus Überla

Selected References

  • Lapuente, D., Storcksdieck genannt Bonsmann, M., Maaske, A., Stab, V., Heinecke, V., Watzstedt, K., Heß, R., Westendorf, A.M., Bayer, W., Ehrhardt, C., Tenbusch, M. (2018). IL-1β as mucosal vaccine adjuvant: The specific induction of tissue-resident memory T cells improves the heterosubtypic immunity against influenza A viruses. Mucosal Immunol. 11: 1265-2178.
  • Lapuente, D., Ruzsics, Z., Thirion, C., Tenbusch, M. (2018). Evaluation of adenovirus 19a as a novel vector for mucosal vaccination against influenza A viruses. Vaccine. 36(19): 2712-2720.
  • Maaske, A., Devos, F.C., Niezold, T., Lapuente, D., Tannapfel, A., Vanoirbeek, J.A., Überla, K., Peters, M., Tenbusch, M. (2016). Mucosal expression of DEC-205 targeted allergen alleviates an asthmatic phenotype in mice. J Control Release. 237: 14-22.
  • Storcksdieck genannt Bonsmann, M., Niezold, T., Hannaman, D., Überla, K., Tenbusch, M. (2016). The improved antibody response against HIV-1 after a vaccination based on intrastructural help is complemented by functional CD8+ T cell responses. Vaccine. 34(15): 1744-1751.
  • Storcksdieck Genannt Bonsmann, M., Niezold, T., Temchura, V., Pissani, F., Ehrhardt, K., Brown, E.P., Osei-Owusu, N.Y., Hannaman, D., Hengel, H., Ackerman, M.E., Streeck, H., Nabi, G., Tenbusch, M.*, Überla, K.* (2015). Enhancing the Quality of Antibodies to HIV-1 Envelope by GagPol-Specific Th Cells. J Immunol. 195(10): 4861-4872. *shared senior authorship.
  • Niezold, T., Storcksdieck Genannt Bonsmann, M., Maaske, A., Temchura, V., Heinecke, V., Hannaman, D., Buer, J., Ehrhardt, C., Hansen, W., Überla, K., Tenbusch, M. (2015). DNA vaccines encoding DEC205-targeted antigens: immunity or tolerance? Immunology. 145(4): 519-533.
  • Grunwald, T.*, Tenbusch, M.*, Schulte, R., Raue, K., Wolf, H., Hannaman, D., de Swart, R.L., Uberla, K., Stahl-Hennig, C. (2014). Novel vaccine regimen elicits strong airway immune responses and control of respiratory syncytial virus in nonhuman primates. J Virol. 88(8): 3997-4007. *shared first authorship.
  • Tenbusch, M., Nchinda, G., Storcksdieck Genannt Bonsmann, M., Temchura, V., Uberla, K. (2013). Targeting the antigen encoded by adenoviral vectors to the DEC205 receptor modulates the cellular and humoral immune response. Int Immunol. 25(4): 247-258.
  • Tenbusch, M., Ignatius, R., Temchura, V., Nabi, G., Tippler, B., Stewart-Jones, G., Salazar, A.M., Sauermann, U., Stahl-Hennig, C., Überla, K. (2012). Risk of immunodeficiency virus infection may increase with vaccine-induced immune response. J Virol. 86(19): 10533-10539.
  • Tenbusch, M., Ignatius, R., Nchinda, G., Trumpfheller, C., Salazar, A.M., Töpfer, K., Sauermann, U., Wagner, R., Hannaman, D., Tenner-Racz, K., Racz, P., Stahl-Hennig, C., Überla, K. (2012). Immunogenicity of DNA vaccines encoding simian immunodeficiency virus antigen targeted to dendritic cells in rhesus macaques. PloS One. 7(6): e39038.